Drawing for NANOREPRO

USPTO serial 97247706

NANOREPRO

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
PERKINS, ELLEN J
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NANOREPRO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeffrey Joyce

100 MIDDLE STREETPORTLAND, ME 04101UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparations and products for healthcare namely SARS-CoV-2 Antigen Rapid Test kits comprised of medical diagnostic test strips, swabs for medical purposes and fluid collection vials for detecting the presence of a virus; pharmaceutical preparations and products for healthcare namely medical diagnostic test kits comprised of medical diagnostic reagents for use in detecting the presence of microorganisms, infectious agents, antibodies, antigens, receptors and contaminants in humans and animals for diagnostic medical use; diagnostic preparations for medical purposes; in vitro diagnostic preparations for medical purposes; medical diagnostic test paper strips for the qualitative detection of SARS-CoV-2 viral nucleocapsid antigens from anterior nasal secretion; medical diagnostic test paper strips for detecting pregnancy and ovulation; biological preparations for medical purposes for the treatment of SARS-CoV-2; chemical preparations for medical purposes for the treatment of SARS-CoV-2; chemical reagents for medical purposes; hormones for medical purposes; diagnostic reagents for detecting SARS-CoV-2 Antigen; monoclonal antibodies for detecting SARS-CoV-2 AntigenACTIVE—
011Air cooling apparatus; cooling apparatus for cryopreservation namely cryogenic freezers and cryorefrigeratorsACTIVE—
035providing business information; providing an online marketplace for buyers and sellers of goods and services; procurement services for third parties, namely, purchasing goods and services namely medical diagnostic reagent test strips, swabs for medical purposes and fluid collection vials for other businesses providing in vitro medical diagnostic test kits, for professional medical or consumer use, for monitoring conditions or diagnosing; import-export agency services; retail store services featuring In vitro medical diagnostic test kits, for professional medical or consumer use, consisting of reagent test strips, reagents and test equipment for monitoring conditions or diagnosing disease; wholesale store services featuring in vitro medical diagnostic test kits, for professional medical or consumer use, consisting of reagent test strips, reagents and test equipment for monitoring conditions or diagnosing disease; advertising copywriting; marketing services; market intelligence services; on-line retail store services featuring in vitro medical diagnostic test kits, for professional medical or consumer use, consisting of reagent test strips, reagents and test equipment for monitoring conditions or diagnosing disease; online wholesale store services featuring in vitro medical diagnostic test kits, for professional medical or consumer use, consisting of reagent test strips, reagents and test equipment for monitoring conditions or diagnosing disease; organization of exhibitions and fairs for commercial and promotional purposes; sales promotion for third parties; advertising; targeted marketing servicesACTIVE—
040Cryopreservation of human tissue, particularly cells and adult stem cells; technical consulting in the field of cryopreservationACTIVE—
042scientific research; scientific analysis in the field of detecting the presence of microorganisms, infectious agents, antibodies, antigens, receptors and contaminants in humans and animals for diagnostic medical use; chemical analyses; scientific and technological services, namely scientific research and testing in the field of SARS-Cov-2 and infectious diseases; scientific laboratory services for technical measurement and testing; biochemical research; stem cell research services; biological research; chemical research; chemistry services namely chemistry consultation; development of pharmaceutical diagnostic tests and rapid diagnostic testsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 12, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 3, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 31, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 5, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 5, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 16, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 3, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 2, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 2, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 2, 2023ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jun 2, 2023GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jun 2, 2023GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 2, 2023CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 21, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 21, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 21, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 21, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 21, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 21, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 14, 2022DOCKASSIGNED TO EXAMINER—
Feb 7, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 4, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance